BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 10920302)

  • 21. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of gynecologic cancers in pregnancy.
    Zanotti KM; Belinson JL; Kennedy AW
    Semin Oncol; 2000 Dec; 27(6):686-98. PubMed ID: 11130476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological detection of heat shock protein hsp27 in normal and breast cancer patients.
    Fanelli MA; Cuello Carrión FD; Dekker J; Schoemaker J; Ciocca DR
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):791-5. PubMed ID: 9752987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunosuppressive acidic protein (IAP) in gynecologic malignant tumors and its relationship with other immunosuppressive substances and cell-mediated immunity].
    Takada M
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt):237-44. PubMed ID: 6881975
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Multiple cancers in gynecologic oncology].
    Schröcksnadel H; Fuith LC; Hetzel H
    Geburtshilfe Frauenheilkd; 1988 Oct; 48(10):710-4. PubMed ID: 3234703
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic 60-kD heat-shock protein responses in alcoholic hepatitis.
    Koskinas J; Winrow VR; Bird GL; Lau JY; Portmann BC; Blake DR; Alexander GJ; Williams R
    Hepatology; 1993 Jun; 17(6):1047-51. PubMed ID: 8514253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cancer-associated serum globulin determined in patients with cervical, endometrial and ovarian cancer.
    Altarac S
    Acta Med Croatica; 1993; 47(1):19-22. PubMed ID: 7693081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-p53 and anti-heat shock proteins antibodies in patients with malignant or pre-malignant lesions of the oral cavity.
    Castelli M; Cianfriglia F; Manieri A; Palma L; Pezzuto RW; Falasca G; Delpino A
    Anticancer Res; 2001; 21(1B):753-8. PubMed ID: 11299839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Importance of CA-50 detection in malignant gynecologic tumors].
    Indraccolo SR; Greco A; Cartechini MG; Compagnucci P
    Minerva Ginecol; 1990 Dec; 42(12):507-9. PubMed ID: 2089292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gynecologic cancers.
    Boente MP; Schilder R; Ozols RF
    Cancer Chemother Biol Response Modif; 1997; 17():536-61. PubMed ID: 9551230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunoglobulin level in malignant gynecologic diseases and tumor patients].
    Pulay T; Keller G; Krommer K; Kovács C
    Orv Hetil; 1973 Dec; 114(52):3146-8. PubMed ID: 4766323
    [No Abstract]   [Full Text] [Related]  

  • 33. Antibodies to the neutral glycolipid asialo ganglio-N-tetraosylceramide: association with gynecologic cancers.
    Witkin SS; Bongiovanni AM; Birnbaum S; Caputo T; Ledger WJ
    Am J Obstet Gynecol; 1985 Mar; 151(5):679-81. PubMed ID: 3976767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shed membrane fragment-associated markers for endometrial and ovarian cancers.
    Taylor DD; Lyons KS; Gerçel-Taylor C
    Gynecol Oncol; 2002 Mar; 84(3):443-8. PubMed ID: 11855885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of serum ferritin in female genital neoplasms].
    Dong MY
    Zhonghua Fu Chan Ke Za Zhi; 1991 Jan; 26(1):21-3, 61. PubMed ID: 1848498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gynecologic malignancies of the elderly.
    Weintraub NT; Freedman ML
    Clin Geriatr Med; 1987 Nov; 3(4):669-94. PubMed ID: 3315162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Preliminary trials of immune function of erythrocytes in women with benign or malignant gynecologic tumors].
    Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 1993 Feb; 28(2):88-90, 123. PubMed ID: 8344089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lymphocyte function and HL-A antigen frequency in gynecologic squamous cancer. A preliminary report.
    Twomey PL; Rogentine GN; Chretien PB
    Int Surg; 1974 Sep; 59(9):468-72. PubMed ID: 4414534
    [No Abstract]   [Full Text] [Related]  

  • 39. The molecular genetics of gyn malignancies.
    Taylor RR; Teneriello MG; Nash JD; Park RC; Birrer MJ
    Oncology (Williston Park); 1994 Oct; 8(10):63-70, 73; discussion 73, 78-82. PubMed ID: 7803216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Radiotherapy of gynecologic cancers].
    Veraguth P; Alessandrini G; Berthier G; Merz WR
    Rev Med Suisse Romande; 1969 May; 89(5):429-47. PubMed ID: 5385887
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.